Navigation Links
Impact with Martin Sheen Exploring Molecular Medicine in a New Report
Date:6/7/2013

Hollywood, CA (PRWEB) June 07, 2013

The producers of Impact Martin Sheen are pleased to announce a new series of reports exploring the nexus between technology and healthcare that is helping to bring new treatments for disease and illness into patient care.

Impact Martin Sheen is an independently produced television series airing in markets around the country on public television. The program is hosted by the legendary Martin Sheen, who is marking the start of his second half-century in American entertainment in 2013. Mr. Sheen has developed a reputation as one of Hollywood’s most respected actors during a career that includes more than 60 film appearances.

Martin Sheen Impact is talking to researchers and other scientists about how molecular medicine is changing how doctors view disease and treatment. By exploring the building blocks of sickness, researchers are able to work on new treatments that attack disease at its very building blocks. In this new report, audiences will see how these new treatments are already showing promise for patients around the world who are suffering from a number of diseases.

The producers of Impact with Martin Sheen will distribute the new report in July. Check local listings for air times on public television and PBS affiliates in individual markets. For more information the producers can be contacted via the official website for the show at impactptv.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10809677.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
2. Social ties have mixed impact on encouraging healthy behaviors in low-income areas
3. Pediatric epilepsy impacts sleep for the child and parents
4. Dartmouth researchers investigate the cognitive effects of athlete head impacts
5. Comprehensive report documents impact of urologic diseases on American public
6. New federal disclosure law may have little impact on drugs prescribed
7. After 25 years, World No Tobacco Day is making an impact
8. Sleep apnea persisting into teens can impact life skills, study finds
9. Racial make-up of community impacts obesity risk
10. LWW announces 57% growth in 2011 impact factor rankings
11. Gastroenterology, CGH maintain strong 2011 impact factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: